The Ocular Surface Case Series is a quarterly video segment featuring experts in the area of ocular surface disease who discuss recent studies and their clinical experience. Christopher E. Starr, MD, FACS, of Weill Cornell Medical College in New York moderates this series and shares his pearls for treating the ocular surface.


Your 25-second video preview has ended.

to continue watching, please Log In or Register:

Log in / Register


previous next

Advances in Psoriasis Treatment: IL-17 Inhibitors

by Jeffery Weinberg, MD, Joshua Zeichner, MD, FAAD

Jeffery Weinberg, MD sits down with host Josh Zeichner, MD to discuss what he describes as a second revolution in the biologic therapy to treat psoriasis. Specifically, he discusses the effectiveness of a new class of biologics, IL-17 inhibitors, including first-in-class secukinumab and the recently approved ixekizumab, as well as brodalumab, which is expected to be approved soon. Dr. Weinberg discusses efficacy, dosing, patient selection, and safety profiles.

More Videos in this Series